Kushinagar News: मार्च 2027 तक पूरी होगी नरचोचवा पेयजल योजना

कुशीनगर, नवम्बर 5 -- Kushinagar News: कुशीनगर। विशुनपुरा ब्लॉक के नरचोचवा गांव में जल जीवन मिशन के तहत निर्माणाधीन ग्रामीण पेयजल योजना का अधिकांश कार्य पूरा हो चुका है। शेष कार्य मार्च 2027 तक पूरा कर... Read More

UPSC Mains Result 2026 : यूपीएससी सिविल सेवा मेन्स रिजल्ट upsc.gov.in पर होगा जारी, ऐसे मिलेगा नेमवाइज परिणाम

नई दिल्ली, नवम्बर 5 -- UPSC Mains Result 2026: यूपीएससी सिविल सेवा मुख्य परीक्षा 2026 का रिजल्ट जारी होने वाला है। परीक्षार्थी अपना परिणाम संघ लोक सेवा आयोग की आधिकारिक वेबसाइट upsc.gov.in पर जाकर चेक... Read More

Oceans under climate stress: AI, satellites, real-time data hold key to protecting global fisheries

Kochi, Nov. 5 -- Climate change is rapidly reshaping the world's oceans, with rising sea temperatures, marine heatwaves, shifting fish populations, coral bleaching and harmful algal blooms emerging as... Read More

EPFO Kochi ranks fourth nationally, tops Kerala in employee enrolment campaign

Kochi, Nov. 5 -- The Employees' Provident Fund Organisation (EPFO), Regional Office, Kochi, has secured the fourth rank nationally and the first position in Kerala in the Employees' Enrolment Campaign... Read More

Singapore Clinical Trial: A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Participants With EGFR-mutated Metastatic Non-small Cell Lung Cancer Whose Disease Has Progressed on Prior Osimertinib and Chemotherapy Combination Treatment (GROVE)

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase II, Open-label Platform Study of Osimertinib in Combination with Anti-cancer Agents in Part... Read More

Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-... Read More

Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabilit... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety o... Read More

Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4174794 in Participants with Obesity or Overweight who are Otherwise Healthy

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose-Escalation Study to E... Read More

Singapore Clinical Trial: A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severely Active Crohn's Disease or Ulcerative Colitis

Singapore, Nov. 5 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severe... Read More

• ««
• «
• 4289
• 4290
• 4291
• 4292
• 4293
• 4294
• 4295
• 4296
• 4297
• 4298
• »
• »»